BC Week In Review | Aug 17, 2015
Company News

Biomics Biotechnologies, Benitec deal

Benitec purchased Biomics’ share in DNA-directed RNAi (ddRNAi)-based HBV drug candidate Hepbarna , which the companies had been developing under a JV. Benitec now has exclusive, worldwide rights to develop and commercialize the preclinical product. Biomics...
Items per page:
1 - 1 of 1